clinical trial · NCT02787746
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
Alzheimer's DiseaseDonepezil
brief summary
This study will evaluate the safety and Efficacy of donepezil in treatment of AD patients in China.
started
Apr 1, 2016
primary completion
Jan 1, 2019
completion
Mar 1, 2019
last updated
Aug 23, 2024
detailed description
This study is a multi-center, single-arm, open labeling clinical trial, which the objective is to evaluate the safety and Efficacy of donepezil in Alzheimer's disease( AD) patients in China, and investigate the relationship between Apo-E gene type with adverse events of donepezil.
official title
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease: A Multi-center Single-arm Study in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol